The Netherlands: NorthSea Therapeutics (NST), a biotech company developing strategies for the treatment of non-alcoholic steatohepatitis (NASH) and other metabolic diseases, has close a US$80m Series C financing round. The…
The Netherlands: NorthSea Therapeutics (NST), a biotech company developing strategies for the treatment of non-alcoholic steatohepatitis (NASH) and other metabolic diseases, has close a US$80m Series C financing round. The…
…
Rankings & Reports
M&A
Equity
Healthcare Investing Review
Healthcare Real Assets Report
Resources & Events
Resource Hub
Sector Events
Private Capital Conference
Real Assets Conference


